GILD logo

Gilead Sciences (GILD) Net income

annual net income:

$480.00M-$5.18B(-91.53%)
December 31, 2024

Summary

  • As of today (April 16, 2025), GILD annual net profit is $480.00 million, with the most recent change of -$5.18 billion (-91.53%) on December 31, 2024.
  • During the last 3 years, GILD annual net income has fallen by -$5.75 billion (-92.29%).
  • GILD annual net income is now -97.35% below its all-time high of $18.11 billion, reached on December 31, 2015.

Performance

GILD Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

quarterly net income:

$1.78B+$530.00M(+42.30%)
December 31, 2024

Summary

  • As of today (April 16, 2025), GILD quarterly net profit is $1.78 billion, with the most recent change of +$530.00 million (+42.30%) on December 31, 2024.
  • Over the past year, GILD quarterly net income has increased by +$530.00 million (+42.30%).
  • GILD quarterly net income is now -61.93% below its all-time high of $4.68 billion, reached on December 31, 2015.

Performance

GILD quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

TTM net income:

$480.00M+$354.00M(+280.95%)
December 31, 2024

Summary

  • As of today (April 16, 2025), GILD TTM net profit is $480.00 million, with the most recent change of +$354.00 million (+280.95%) on December 31, 2024.
  • Over the past year, GILD TTM net income has increased by +$354.00 million (+280.95%).
  • GILD TTM net income is now -97.35% below its all-time high of $18.11 billion, reached on December 31, 2015.

Performance

GILD TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

GILD Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-91.5%+42.3%+280.9%
3 y3 years-92.3%+42.3%+280.9%
5 y5 years-91.1%+42.3%+280.9%

GILD Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.3%at low-18.2%+142.8%-91.8%+280.9%
5 y5-year-92.3%+290.2%-31.2%+142.8%-93.5%+286.8%
alltimeall time-97.3%+140.3%-61.9%+142.8%-97.3%+140.3%

Gilead Sciences Net income History

DateAnnualQuarterlyTTM
Dec 2024
$480.00M(-91.5%)
$1.78B(+42.3%)
$480.00M(+281.0%)
Sep 2024
-
$1.25B(-22.4%)
$126.00M(-88.0%)
Jun 2024
-
$1.61B(-138.7%)
$1.05B(+117.6%)
Mar 2024
-
-$4.17B(-391.8%)
$484.00M(-91.5%)
Dec 2023
$5.67B(+23.4%)
$1.43B(-34.4%)
$5.66B(-3.6%)
Sep 2023
-
$2.18B(+108.6%)
$5.88B(+7.1%)
Jun 2023
-
$1.04B(+3.5%)
$5.48B(-1.8%)
Mar 2023
-
$1.01B(-38.4%)
$5.58B(+21.6%)
Dec 2022
$4.59B(-26.2%)
$1.64B(-8.3%)
$4.59B(+37.7%)
Sep 2022
-
$1.79B(+56.4%)
$3.33B(-19.4%)
Jun 2022
-
$1.14B(+5921.1%)
$4.14B(-8.4%)
Mar 2022
-
$19.00M(-95.0%)
$4.51B(-27.5%)
Dec 2021
$6.22B(+4961.0%)
$382.00M(-85.3%)
$6.22B(-15.8%)
Sep 2021
-
$2.59B(+70.3%)
$7.39B(+43.2%)
Jun 2021
-
$1.52B(-12.0%)
$5.16B(+1615.0%)
Mar 2021
-
$1.73B(+11.5%)
$301.00M(+144.7%)
Dec 2020
$123.00M(-97.7%)
$1.55B(+330.8%)
$123.00M(-90.3%)
Sep 2020
-
$360.00M(-110.8%)
$1.27B(-593.4%)
Jun 2020
-
-$3.34B(-315.3%)
-$257.00M(-105.2%)
Mar 2020
-
$1.55B(-42.5%)
$4.96B(-7.9%)
Dec 2019
$5.39B(-1.3%)
$2.70B(-331.4%)
$5.39B(+100.0%)
Sep 2019
-
-$1.17B(-162.0%)
$2.69B(-54.8%)
Jun 2019
-
$1.88B(-4.8%)
$5.96B(+1.1%)
Mar 2019
-
$1.98B(>+9900.0%)
$5.89B(+8.0%)
Dec 2018
$5.46B(+17.9%)
$3.00M(-99.9%)
$5.46B(+243.7%)
Sep 2018
-
$2.10B(+15.4%)
$1.59B(-28.1%)
Jun 2018
-
$1.82B(+18.1%)
$2.21B(-36.3%)
Mar 2018
-
$1.54B(-139.8%)
$3.46B(-25.2%)
Dec 2017
$4.63B(-65.7%)
-$3.87B(-242.2%)
$4.63B(-60.1%)
Sep 2017
-
$2.72B(-11.6%)
$11.60B(-5.0%)
Jun 2017
-
$3.07B(+13.7%)
$12.21B(-3.4%)
Mar 2017
-
$2.70B(-13.1%)
$12.64B(-6.4%)
Dec 2016
$13.50B(-25.4%)
$3.11B(-6.7%)
$13.50B(-10.4%)
Sep 2016
-
$3.33B(-4.8%)
$15.08B(-7.8%)
Jun 2016
-
$3.50B(-1.9%)
$16.35B(-5.7%)
Mar 2016
-
$3.57B(-23.9%)
$17.34B(-4.2%)
Dec 2015
$18.11B(+49.6%)
$4.68B(+1.8%)
$18.11B(+7.1%)
Sep 2015
-
$4.60B(+2.4%)
$16.91B(+12.4%)
Jun 2015
-
$4.49B(+3.7%)
$15.04B(+5.9%)
Mar 2015
-
$4.33B(+24.3%)
$14.21B(+17.4%)
Dec 2014
$12.10B(+293.5%)
$3.49B(+27.7%)
$12.10B(+28.7%)
Sep 2014
-
$2.73B(-25.3%)
$9.41B(+26.0%)
Jun 2014
-
$3.66B(+64.2%)
$7.46B(+63.0%)
Mar 2014
-
$2.23B(+181.3%)
$4.58B(+48.9%)
Dec 2013
$3.08B(+18.6%)
$791.60M(+0.4%)
$3.08B(+0.9%)
Sep 2013
-
$788.61M(+2.1%)
$3.05B(+3.9%)
Jun 2013
-
$772.61M(+7.0%)
$2.93B(+2.1%)
Mar 2013
-
$722.19M(-5.3%)
$2.87B(+10.8%)
Dec 2012
$2.59B(-7.5%)
$762.98M(+12.9%)
$2.59B(+3.9%)
Sep 2012
-
$675.50M(-5.1%)
$2.49B(-2.6%)
Jun 2012
-
$711.56M(+61.0%)
$2.56B(-1.3%)
Mar 2012
-
$441.96M(-33.6%)
$2.59B(-7.5%)
Dec 2011
$2.80B(-3.4%)
$665.14M(-10.3%)
$2.80B(+1.3%)
Sep 2011
-
$741.12M(-0.7%)
$2.77B(+1.3%)
Jun 2011
-
$746.23M(+14.6%)
$2.73B(+1.3%)
Mar 2011
-
$651.14M(+3.5%)
$2.70B(-7.0%)
Dec 2010
$2.90B(+10.1%)
$629.42M(-10.7%)
$2.90B(-5.6%)
Sep 2010
-
$704.88M(-1.0%)
$3.07B(+1.0%)
Jun 2010
-
$712.06M(-16.7%)
$3.04B(+4.8%)
Mar 2010
-
$854.90M(+6.6%)
$2.90B(+10.1%)
Dec 2009
$2.64B(+33.2%)
$802.21M(+19.2%)
$2.64B(+11.2%)
Sep 2009
-
$673.03M(+17.8%)
$2.37B(+7.7%)
Jun 2009
-
$571.40M(-3.0%)
$2.20B(+6.6%)
Mar 2009
-
$589.11M(+9.9%)
$2.06B(+5.1%)
Dec 2008
$1.98B(+22.5%)
$535.94M(+6.3%)
$1.96B(+7.3%)
Sep 2008
-
$504.00M(+15.9%)
$1.83B(+6.1%)
Jun 2008
-
$434.78M(-11.0%)
$1.72B(+1.6%)
Mar 2008
-
$488.30M(+21.6%)
$1.70B(+5.0%)
Dec 2007
$1.62B
$401.64M(+0.8%)
$1.62B(-457.4%)
Sep 2007
-
$398.32M(-2.4%)
-$451.99M(-49.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
$407.93M(+0.1%)
-$902.47M(-13.7%)
Mar 2007
-
$407.41M(-124.5%)
-$1.05B(-12.2%)
Dec 2006
-$1.19B(-246.2%)
-$1.67B(+3093.1%)
-$1.19B(-257.1%)
Sep 2006
-
-$52.16M(-119.7%)
$757.29M(-23.4%)
Jun 2006
-
$265.15M(+0.9%)
$988.69M(+7.5%)
Mar 2006
-
$262.70M(-6.7%)
$919.50M(+13.0%)
Dec 2005
$813.91M(+81.1%)
$281.60M(+57.1%)
$813.91M(+26.7%)
Sep 2005
-
$179.23M(-8.5%)
$642.56M(+11.4%)
Jun 2005
-
$195.97M(+24.7%)
$576.56M(+17.2%)
Mar 2005
-
$157.11M(+42.5%)
$492.06M(+9.5%)
Dec 2004
$449.37M(-724.1%)
$110.24M(-2.6%)
$449.37M(-15.5%)
Sep 2004
-
$113.24M(+1.6%)
$531.71M(+8.2%)
Jun 2004
-
$111.46M(-2.6%)
$491.57M(+2.3%)
Mar 2004
-
$114.43M(-40.6%)
$480.48M(-767.3%)
Dec 2003
-$72.00M(-199.9%)
$192.58M(+163.5%)
-$72.00M(-68.6%)
Sep 2003
-
$73.10M(-27.2%)
-$229.11M(-18.6%)
Jun 2003
-
$100.37M(-122.9%)
-$281.45M(-22.3%)
Mar 2003
-
-$438.05M(-1334.7%)
-$362.11M(-602.2%)
Dec 2002
$72.10M(+37.9%)
$35.48M(+70.9%)
$72.10M(-57.1%)
Sep 2002
-
$20.76M(+5.3%)
$168.19M(+37.6%)
Jun 2002
-
$19.71M(-612.0%)
$122.24M(+74.3%)
Mar 2002
-
-$3.85M(-102.9%)
$70.14M(+34.2%)
Dec 2001
$52.27M(-192.1%)
$131.58M(-622.2%)
$52.27M(-148.1%)
Sep 2001
-
-$25.20M(-22.2%)
-$108.57M(+7.6%)
Jun 2001
-
-$32.39M(+49.1%)
-$100.94M(+39.1%)
Mar 2001
-
-$21.72M(-25.8%)
-$72.59M(+2.1%)
Dec 2000
-$56.78M(-14.6%)
-$29.27M(+66.6%)
-$71.08M(+39.9%)
Sep 2000
-
-$17.56M(+335.2%)
-$50.81M(-20.2%)
Jun 2000
-
-$4.04M(-80.0%)
-$63.65M(-10.7%)
Mar 2000
-
-$20.21M(+124.6%)
-$71.30M(+7.1%)
Dec 1999
-$66.50M(+48.4%)
-$9.00M(-70.4%)
-$66.57M(-12.7%)
Sep 1999
-
-$30.40M(+160.0%)
-$76.27M(+74.7%)
Jun 1999
-
-$11.69M(-24.5%)
-$43.67M(-6.6%)
Mar 1999
-
-$15.48M(-17.2%)
-$46.78M(+20.9%)
Dec 1998
-$44.80M(-38.5%)
-$18.70M(-950.0%)
-$38.70M(-49.9%)
Sep 1998
-
$2.20M(-114.9%)
-$77.30M(-13.9%)
Jun 1998
-
-$14.80M(+100.0%)
-$89.80M(+24.2%)
Mar 1998
-
-$7.40M(-87.1%)
-$72.30M(-0.7%)
Dec 1997
-$72.90M(+235.9%)
-$57.30M(+456.3%)
-$72.80M(+209.8%)
Sep 1997
-
-$10.30M(-481.5%)
-$23.50M(+502.6%)
Jun 1997
-
$2.70M(-134.2%)
-$3.90M(-79.3%)
Mar 1997
-
-$7.90M(-1.3%)
-$18.80M(-13.4%)
Dec 1996
-$21.70M(-20.8%)
-$8.00M(-186.0%)
-$21.70M(+58.4%)
Sep 1996
-
$9.30M(-176.2%)
-$13.70M(-56.4%)
Jun 1996
-
-$12.20M(+13.0%)
-$31.40M(+15.9%)
Mar 1996
-
-$10.80M(+28.6%)
-$27.10M(-18.9%)
Dec 1995
-$27.40M(-12.5%)
-
-
Sep 1995
-
-$8.40M(+6.3%)
-$33.40M(+4.4%)
Jun 1995
-
-$7.90M(-11.2%)
-$32.00M(+2.2%)
Mar 1995
-
-$8.90M(+8.5%)
-$31.30M(+1.6%)
Mar 1995
-$31.30M(+21.8%)
-
-
Dec 1994
-
-$8.20M(+17.1%)
-$30.80M(+5.1%)
Sep 1994
-
-$7.00M(-2.8%)
-$29.30M(+4.3%)
Jun 1994
-
-$7.20M(-14.3%)
-$28.10M(+9.3%)
Mar 1994
-$25.70M(+82.3%)
-$8.40M(+25.4%)
-$25.70M(+11.7%)
Dec 1993
-
-$6.70M(+15.5%)
-$23.00M(+13.9%)
Sep 1993
-
-$5.80M(+20.8%)
-$20.20M(+18.1%)
Jun 1993
-
-$4.80M(-15.8%)
-$17.10M(+21.3%)
Mar 1993
-$14.10M(+213.3%)
-$5.70M(+46.2%)
-$14.10M(+45.4%)
Dec 1992
-
-$3.90M(+44.4%)
-$9.70M(+36.6%)
Sep 1992
-
-$2.70M(+50.0%)
-$7.10M(+34.0%)
Jun 1992
-
-$1.80M(+38.5%)
-$5.30M(+20.5%)
Mar 1992
-$4.50M(+12.5%)
-$1.30M(0.0%)
-$4.40M(+7.3%)
Dec 1991
-
-$1.30M(+44.4%)
-$4.10M(+10.8%)
Sep 1991
-
-$900.00K(0.0%)
-$3.70M(-2.6%)
Jun 1991
-
-$900.00K(-10.0%)
-$3.80M(-2.6%)
Mar 1991
-$4.00M
-$1.00M(+11.1%)
-$3.90M(+34.5%)
Dec 1990
-
-$900.00K(-10.0%)
-$2.90M(+45.0%)
Sep 1990
-
-$1.00M(0.0%)
-$2.00M(+100.0%)
Jun 1990
-
-$1.00M
-$1.00M

FAQ

  • What is Gilead Sciences annual net profit?
  • What is the all time high annual net income for Gilead Sciences?
  • What is Gilead Sciences annual net income year-on-year change?
  • What is Gilead Sciences quarterly net profit?
  • What is the all time high quarterly net income for Gilead Sciences?
  • What is Gilead Sciences quarterly net income year-on-year change?
  • What is Gilead Sciences TTM net profit?
  • What is the all time high TTM net income for Gilead Sciences?
  • What is Gilead Sciences TTM net income year-on-year change?

What is Gilead Sciences annual net profit?

The current annual net income of GILD is $480.00M

What is the all time high annual net income for Gilead Sciences?

Gilead Sciences all-time high annual net profit is $18.11B

What is Gilead Sciences annual net income year-on-year change?

Over the past year, GILD annual net profit has changed by -$5.18B (-91.53%)

What is Gilead Sciences quarterly net profit?

The current quarterly net income of GILD is $1.78B

What is the all time high quarterly net income for Gilead Sciences?

Gilead Sciences all-time high quarterly net profit is $4.68B

What is Gilead Sciences quarterly net income year-on-year change?

Over the past year, GILD quarterly net profit has changed by +$530.00M (+42.30%)

What is Gilead Sciences TTM net profit?

The current TTM net income of GILD is $480.00M

What is the all time high TTM net income for Gilead Sciences?

Gilead Sciences all-time high TTM net profit is $18.11B

What is Gilead Sciences TTM net income year-on-year change?

Over the past year, GILD TTM net profit has changed by +$354.00M (+280.95%)
On this page